Osteoporosis News and Research RSS Feed - Osteoporosis News and Research Twitter

Osteoporosis is a debilitating disease that affects an estimated 75 million people in Europe, U.S. and Japan. Osteoporosis, which means "porous bone," is a disease in which the density and quality of bone are reduced. As the bones become more porous and fragile, the risk of fracture is greatly increased. The loss of bone occurs "silently" and progressively and no symptoms are apparent until the first fracture occurs. The most common fractures associated with osteoporosis occur at the hip, spine and wrist. The incidence of these fractures, particularly at the hip and spine, increases with age in both women and men. Vertebral fractures can result in serious consequences, including loss of height, intense back pain and deformity.

Study shows 30.4% of hip fracture patients in India died within one year

In various studies across different countries the reported one year mortality risks after hip fracture can vary anywhere from 5 to 50 %. In India, however, there has been little research on the risk of mortality and functional impairment following hip fracture. [More]

Belgian investigators present study results of hip fracture in older patients at ESCEO13-IOF

Although hip fractures in older patients are known to be a major cause of long term disability and increased risk of death, less is known about the relationship between surgical delay after hip fracture and mortality risk. [More]
Investigator honored for advancing osteoporosis research and advocacy worldwide

Investigator honored for advancing osteoporosis research and advocacy worldwide

Professor Socrates Papapoulos, a long standing member of the IOF Board and leading researcher at the Leiden University Medical Center, has been named the recipient of the prestigious Pierre Delmas Award. [More]
Clinical Research Forum honors studies with potential to benefit human health and welfare

Clinical Research Forum honors studies with potential to benefit human health and welfare

Ten of the most outstanding clinical research projects from institutions around the country have been selected to receive the Clinical Research Forum's Annual Top 10 Clinical Research Achievement Awards. [More]
AACE publishes comprehensive diabetes management algorithm to treat prediabetes, T2DM patients

AACE publishes comprehensive diabetes management algorithm to treat prediabetes, T2DM patients

The American Association of Clinical Endocrinologists today announced the publication of its comprehensive diabetes management algorithm created to guide primary care physicians, endocrinologists and other health care professionals in the treatment of prediabetes and type 2 diabetes mellitus patients. [More]
IOF honors Spanish researcher for contributions to clinical research in the field of osteoporosis

IOF honors Spanish researcher for contributions to clinical research in the field of osteoporosis

The IOF Medal of Achievement has been presented today to Professor Adolfo Diez-Perez, MD, PhD, Head Emeritus of the Department of Internal Medicine, Hospital del Mar, Director of the Bone and Joint Research Unit at the Municipal Institute of Medical Research and Professor of Medicine at the Autonomous University of Barcelona. [More]

Clinical Research Forum honors Margaret Gourlay with Top 10 Clinical Research Achievement Award

For leading a study that was the first to define appropriate bone density screening intervals for older women, Margaret Gourlay, MD, MPH, of the University of North Carolina School of Medicine has been honored with a Top 10 Clinical Research Achievement Award from the Clinical Research Forum. [More]
Study: Primary medication nonadherence can lead to increased risk of bone fractures

Study: Primary medication nonadherence can lead to increased risk of bone fractures

Nearly 30 percent of women failed to pick up their bisphosphonate prescriptions, a medication that is most commonly used to treat osteoporosis and similar bone diseases, according to a Kaiser Permanente study published this week in the journal Osteoporosis International. [More]
UCSF Professor receives Olof Johnell Science Award for achievements in metabolic bone disease

UCSF Professor receives Olof Johnell Science Award for achievements in metabolic bone disease

Harry Genant, Professor Emeritus of the University of California San Francisco, has been named the winner of the International Osteoporosis Foundation's (IOF) first Olof Johnell Science Award. [More]

New report reveals growing burden of osteoporosis in all 27 member states of EU

A new report prepared in collaboration with the International Osteoporosis Foundation and the European Federation of Pharmaceutical Industry Associations, is the first to describe in detail the epidemiology, burden, and treatment of osteoporosis in all 27 member states of the European Union. [More]

University of Florence professor awarded ESCEO-IOF Servier Pierre D. Delmas Prize

Today, at the opening of the European Congress on Osteoporosis & Osteoarthritis in Rome, Italy, Professor Maria Luisa Brandi MD, Professor of Endocrinology and Metabolic Diseases at the University of Florence, Florence, Italy was presented with ESCEO-IOF Servier Pierre D. Delmas Prize. [More]

ESCEO and IOF honor Dr. Mary L. Bouxsein with ESCEO-IOF Herbert Fleisch Medal

Dr. Mary L. Bouxsein has been awarded the ESCEO-IOF Herbert Fleisch Medal in honor of her work in the field of skeletal fragility. [More]

European Congress on Osteoporosis & Osteoarthritis starts in Rome

The world's largest congress dedicated to the epidemiology, pathogenesis, prevention, and treatment of osteoporosis and osteoarthritis has opened today in Rome, Italy with 4500 delegates. [More]
Scorecard compares how countries within EU care for people with osteoporosis

Scorecard compares how countries within EU care for people with osteoporosis

Today a panel of international experts working in cooperation with the International Osteoporosis Foundation have published SCOPE - or Scorecard for Osteoporosis in Europe. [More]
Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

Omeros Corporation today announced positive data in the most commonly used model for studying the clinical and pathological features of multiple sclerosis (MS), further advancing its development program of GPR17-targeting compounds for the treatment of MS. Compounds previously discovered by Omeros that inhibit GPR17, an orphan G protein-coupled receptor (GPCR) unlocked by Omeros, significantly improved function from experimental autoimmune encephalomyelitis (EAE) in mice. [More]
Rheumatoid arthritis blood tests launched by Quest Diagnostics

Rheumatoid arthritis blood tests launched by Quest Diagnostics

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced the availability of two new blood tests for aiding the early diagnosis of arthritis (RA), an autoimmune disorder that can cause debilitating joint damage. [More]
Research identifies important role of zinc in kidney stone formation

Research identifies important role of zinc in kidney stone formation

Kidney stones usually make their presence known suddenly, often sending a person to the hospital in excruciating pain. Each year in the U.S. more than a million people seek medical attention for kidney stones, technically called nephrolithiasis. [More]
Updated guidelines for metabolic and bariatric surgery

Updated guidelines for metabolic and bariatric surgery

Significant new scientific evidence published over the last four years has prompted three major medical societies to change its guidance on who should get metabolic and bariatric surgery and which methods should be used. [More]
Study shows smoking and depression in adolescent girls have negative impact on bone mineral density

Study shows smoking and depression in adolescent girls have negative impact on bone mineral density

First-Time Study Shows Smoking and Depression in Adolescents have Negative Impact on Bone Mineral Density, say Investigators in the Journal of Adolescent Health [More]

Lifestyle choices we make in adulthood influence how tall we stand as we age

Even if you didn't eat your veggies or drink your milk as a child, your height is still in your hands, reveal new findings by economists from the University of Southern California, Harvard University and Peking University. [More]